New research led by Dr. Maria Gloria Dominguez-Bello indicates a promising new therapy for babies born by c-section. Cesarean infants typically have less diverse microbiomes when compared to babies born vaginally, a factor associated with increased risk for immune and metabolic disorders. In the study, described in Nature Medicine, infants delivered by c-section were swabbed with their mothers' vaginal fluids immediately upon being born. Subsequently, the gut, oral and skin bacterial communities of these babies was enriched and more closely resembled those who were delivered vaginally. Dr. Alexander Khoruts, MD, of the University of Minnesota's Microbiota Therapeutics Program, discussed the research and its implications in an article also published in Nature Medicine. On Wednesday, Feb. 17, Dr. Khoruts will be lecturing on Dr. Gloria Dominguez-Bello's research, his own pioneering therapeutic interventions, and the threat of antibiotic-resistant rogue superbugs.